TMates Review
Best for: nationwide compounded GLP-1 availability including Puerto Rico
TMates is a Miami-based telehealth platform offering compounded semaglutide ($199/mo) and tirzepatide ($297/mo) across all 50 states plus Puerto Rico, operating on a messaging-first model with independent licensed prescribers and third-party compounding pharmacies.
Medium confidence · Last verified 2026-04-09 via manual · How we verify provider data
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
The Bottom Line
TMates is a solid telehealth option with balanced features and pricing.
Score Breakdown
Pricing
| Dose | Form | Price/mo |
|---|---|---|
| Starting | compounded | $199 |
| Starting | compounded | $297 |
✓ Pros
- •All-inclusive monthly pricing covers medication, consultations, nutrition coaching, and 24/7 support with no separate membership fee
- •Available in all 50 US states plus Puerto Rico and other US territories
- •Both compounded semaglutide and tirzepatide offered
- •Fast stated turnaround (intake to medication delivery in 2–3 days)
✗ Cons
- •No disclosed third-party accreditations (no verified LegitScript, PCAB, ACHC, or NABP) — weaker pharmacy-oversight signal than competitors
- •BBB rating B+ (not accredited) with 8 complaints filed, most involving billing and cancellation friction
- •Trustpilot reviews show partial-refund and contact-difficulty reports, and some customer posts allege reviews have been removed
- •Compounded only — no FDA-approved Ozempic, Wegovy, Zepbound, or Mounjaro
- •Pharmacy partners not publicly named — TMates explicitly disclaims both medical practice and pharmacy dispensing responsibility, routing both to independent third parties
- •Also sells Schedule III testosterone products and other wellness SKUs alongside GLP-1s — worth knowing about for readers who want a GLP-1-focused provider
Ready to start with TMates?
Starting at $199/month. See current pricing and start your free consultation.
Sources & methodology
Our TMates review applies the same 6-dimension scoring framework we use for every provider. Pricing, FDA approval status, compounding rules, and clinical-trial efficacy claims are sourced from the primary regulatory and peer-reviewed literature below.
Sources & methodology — as of April 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
Alternatives to TMates
Editorial score · methodology
Amazon Pharmacy
Best for: fastest brand-name Foundayo delivery with the cheapest insured price
Editorial score · methodology
Editorial score · methodology
Frequently Asked Questions
Ready to start with TMates?
Starting at $199/month. See current pricing and start your free consultation.